Work

A phase II study of acalabrutinib in combination with R-CHOP for previously untreated transplant-ineligible mantle cell lymphoma patients in Spain (the SOUND-MCL Study)

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-1838

Authors: Ana Marin Niebla, Alejandro Martin Garcia-Sancho, Jorge Castro García, Esther Álvarez García, Ángel Callejo Mellén, Juan-Manuel Sancho

Institutions: Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca, AstraZeneca (Spain), Hospital Universitari Germans Trias i Pujol

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417001903

Cites:

Cited by:

Related to: